HeartBeam Profit Margin 2020-2023 | BEAT
Current and historical gross margin, operating margin and net profit margin for HeartBeam (BEAT) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. HeartBeam net profit margin as of September 30, 2023 is 0%.
| HeartBeam Annual Profit Margins |
|---|
| HeartBeam Quarterly Profit Margins |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.057B | $0.000B |
| HeartBeam Inc. is a development stage digital healthcare company with proprietary ECG telemedicine technology. HeartBeam Inc. is based in SANTA CLARA, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $38.875B | 21.62 |
| Inspire Medical Systems (INSP) | United States | $7.378B | 0.00 |
| 10x Genomics (TXG) | United States | $3.475B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.470B | 0.00 |
| Axonics (AXNX) | United States | $3.427B | 0.00 |
| Enovis (ENOV) | United States | $3.084B | 23.43 |
| Azenta (AZTA) | United States | $2.854B | 232.59 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.772B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.659B | 0.00 |
| Privia Health (PRVA) | United States | $2.118B | 93.95 |
| Schrodinger (SDGR) | United States | $1.811B | 0.00 |
| Phreesia (PHR) | United States | $1.306B | 0.00 |
| Omnicell (OMCL) | United States | $1.206B | 29.52 |
| Definitive Healthcare (DH) | United States | $0.847B | 0.00 |
| Standard BioTools (LAB) | United States | $0.757B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.601B | 0.00 |
| Talkspace (TALK) | United States | $0.497B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.329B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.316B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.308B | 0.00 |
| Pulmonx (LUNG) | United States | $0.286B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.171B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.158B | 0.00 |
| Augmedix (AUGX) | United States | $0.155B | 0.00 |
| American Well (AMWL) | United States | $0.149B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.131B | 0.00 |
| TruBridge (TBRG) | United States | $0.122B | 5.19 |
| Outset Medical (OM) | United States | $0.112B | 0.00 |
| 111 (YI) | China | $0.081B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.076B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.076B | 0.00 |
| Zepp Health (ZEPP) | China | $0.051B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.042B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.033B | 0.00 |
| Movano (MOVE) | United States | $0.026B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Cue Health (HLTH) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.021B | 0.00 |
| ETAO (ETAO) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.018B | 0.00 |
| Akili (AKLI) | United States | $0.017B | 0.00 |
| Centogene (CNTG) | Germany | $0.013B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.010B | 0.00 |
| Syra Health (SYRA) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |